NO991558L - Meningokokkvaksine som omfatter valensen til stamme BZ83 - Google Patents
Meningokokkvaksine som omfatter valensen til stamme BZ83Info
- Publication number
- NO991558L NO991558L NO991558A NO991558A NO991558L NO 991558 L NO991558 L NO 991558L NO 991558 A NO991558 A NO 991558A NO 991558 A NO991558 A NO 991558A NO 991558 L NO991558 L NO 991558L
- Authority
- NO
- Norway
- Prior art keywords
- strain
- tbpb
- formula
- sequence encoding
- dna sequence
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9710301A FR2767060B1 (fr) | 1997-08-07 | 1997-08-07 | Vaccin meningocoque comportant la valence de souche bz83 |
PCT/FR1998/001730 WO1999007741A1 (fr) | 1997-08-07 | 1998-08-03 | Vaccin meningocoque comportant la valence de souche bz83 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO991558D0 NO991558D0 (no) | 1999-03-30 |
NO991558L true NO991558L (no) | 1999-03-30 |
Family
ID=9510254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO991558A NO991558L (no) | 1997-08-07 | 1999-03-30 | Meningokokkvaksine som omfatter valensen til stamme BZ83 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0948534A1 (fr) |
JP (1) | JP2001503068A (fr) |
CN (1) | CN1241193A (fr) |
AU (1) | AU8987598A (fr) |
CA (1) | CA2267066A1 (fr) |
FR (1) | FR2767060B1 (fr) |
HU (1) | HUP0001451A3 (fr) |
NO (1) | NO991558L (fr) |
NZ (1) | NZ334992A (fr) |
WO (1) | WO1999007741A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0107219D0 (en) * | 2001-03-22 | 2001-05-16 | Microbiological Res Authority | Immunogenic commensal neisseria sequences |
JP2016539950A (ja) * | 2013-12-02 | 2016-12-22 | ビー. シュライバーズ,アンソニー | 細菌表面受容体タンパク質由来の免疫原性組成物およびワクチン |
WO2016091902A1 (fr) * | 2014-12-09 | 2016-06-16 | Sanofi Pasteur | Compositions comprenant des protéines de n. meningitidis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292869A (en) * | 1989-04-27 | 1994-03-08 | The Board Of Governors Of The University | Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same |
FR2682041B1 (fr) * | 1991-10-03 | 1994-01-14 | Pasteur Merieux Serums Vaccins | Vaccin contre les infections a neisseria meningitidis. |
FR2692592B1 (fr) * | 1992-06-19 | 1995-03-31 | Pasteur Merieux Serums Vacc | Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant. |
FR2720408B1 (fr) * | 1994-05-31 | 1996-08-14 | Pasteur Merieux Serums Vacc | Fragments Tbp2 de Neisseria meningitidis. |
FR2739624B1 (fr) * | 1995-10-10 | 1997-12-05 | Pasteur Merieux Serums Vacc | Nouvelle sous-unite tbp2 de neisseria meningitidis |
-
1997
- 1997-08-07 FR FR9710301A patent/FR2767060B1/fr not_active Expired - Fee Related
-
1998
- 1998-08-03 NZ NZ334992A patent/NZ334992A/en unknown
- 1998-08-03 CA CA002267066A patent/CA2267066A1/fr not_active Abandoned
- 1998-08-03 CN CN98801479A patent/CN1241193A/zh active Pending
- 1998-08-03 HU HU0001451A patent/HUP0001451A3/hu unknown
- 1998-08-03 WO PCT/FR1998/001730 patent/WO1999007741A1/fr not_active Application Discontinuation
- 1998-08-03 JP JP11511756A patent/JP2001503068A/ja active Pending
- 1998-08-03 EP EP98941530A patent/EP0948534A1/fr not_active Withdrawn
- 1998-08-03 AU AU89875/98A patent/AU8987598A/en not_active Abandoned
-
1999
- 1999-03-30 NO NO991558A patent/NO991558L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ334992A (en) | 2001-09-28 |
NO991558D0 (no) | 1999-03-30 |
JP2001503068A (ja) | 2001-03-06 |
HUP0001451A3 (en) | 2001-09-28 |
EP0948534A1 (fr) | 1999-10-13 |
CA2267066A1 (fr) | 1999-02-18 |
WO1999007741A1 (fr) | 1999-02-18 |
FR2767060A1 (fr) | 1999-02-12 |
AU8987598A (en) | 1999-03-01 |
FR2767060B1 (fr) | 2000-02-11 |
CN1241193A (zh) | 2000-01-12 |
HUP0001451A2 (hu) | 2001-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Erdmann et al. | The involvement of 5S RNA in the binding of tRNA to ribosomes | |
Hamy et al. | Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA | |
Krakow et al. | Ribonucleic acid polymerase of azotobacter Vinelandii, I. Priming by Polyribonucleotides | |
Leiden et al. | A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells | |
ATE394410T1 (de) | Hochspezifische primer, amplifizierungsverfahren und kits | |
NO976144D0 (no) | Sammensetning basert på zirkoniumoksyd og ceriumoksyd, fremgangsmåte for dens fremstilling og anvendelse derav | |
EP0752887A4 (fr) | Virus d'immunodeficience de recombinaison de la variole | |
AU6769590A (en) | Cloned dna sequences, hybridizable with genomic rna of lymphadenopathy-associated virus (lav) | |
BR9807062A (pt) | Purificação ou\e concentração de dna através de separação por filtração de fluxo cruzado de endotoxinas de uma preparação de ácidos nucléicos | |
NO991558L (no) | Meningokokkvaksine som omfatter valensen til stamme BZ83 | |
DE69808743D1 (en) | Netrinrezeptoren | |
DE60101372D1 (de) | Pyrimidinverbindungen und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität | |
Yang et al. | Specificity and mechanism of antitermination by Q proteins of bacteriophages λ and 82 | |
DE69923587D1 (de) | Nichtpeptidische antagonisten des glp-1 rezeptors und verwendungsmethoden | |
GB9310657D0 (en) | Retrovirus | |
NO951689L (no) | DNA som koder for en human serotoninreseptor (5-HT4B) og anvendelse av denne | |
NO20065582L (no) | (1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer | |
ES2216619T3 (es) | Vacuna viral. | |
Allsopp et al. | Sequence analysis of HLA-Bw53, a common West African allele, suggests an origin by gene conversion of HLA-B35 | |
Leavitt et al. | Nucleotide sequence of Bacillus phage Nf terminal protein gene | |
Schwarz et al. | Nested RT-PCR for detection of sandfly fever virus, serotype Toscana, in clinical specimens, with confirmation by nucleotide sequence analysis | |
JPS643040A (en) | Chemical admixture for cement | |
EP1813289A4 (fr) | Composition médicinale pour le traitement du cancer ou du diabète | |
KR20080085398A (ko) | 순환적 역전사 방법 | |
Miwa et al. | Development of polymorphic microsatellite markers in a tropical tree species, Melaleuca cajuputi (Myrtaceae). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |